ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Result Summary for Survey:Thoracic Portal Survey - VATS Lobectomy Training and Instruction
In this survey respondents were asked about their routine approach to assessment and management of patients with non-thymomatous myasthenia gravis (MG). The majority of respondents surgically manage myasthenia gravis. Two-thirds of them perform this operation via a full or partial sternotomy. About 20% of surgeons use VATS approaches, and transcervical and robotic approaches each were used by 5%.
Almost 85% of respondents consider the diagnosis of myasthenia gravis or MG with more than ocular symptoms to be sufficient indications for surgery. A minority of surgeons, just over 15%, indicated that patients needed to have generalized symptoms before they would consider recommending thymectomy. The most common surgical goal, favored by two-thirds of respondents, was complete thymectomy, whereas one-third believe that an extended or radical thymectomy is appropriate for management of MG.
Advanced age does not appear to be a contraindication to thymectomy for MG, even though some reports in the literature suggest that outcomes with regards to resolution of MG symptoms are not as favorable in older patients. Preoperative preparation appears to include 2 or more different techniques for most surgeons.
Almost all surgeons obtain a CT scan as part of the preoperative evaluation. Only 40% measure lung function, and just over 50% assess acetylcholine receptor antibody status. MRI is not favored as a method of preoperative evaluation in these patients. Interestingly, if a small encapsulated nodule consistent with a thymoma is discovered during a minimally invasive thymectomy, two-thirds of respondents would complete the thymectomy using a minimally invasive approach.
This was the first survey in this portal to attract relatively equal numbers of respondents from North America, Europe, and Asia, and there was a larger number than usual of respondents from Africa as well.
1. Do you perform thymectomy for myasthenia gravis? | |||
---|---|---|---|
answered question | 113 | ||
|
skipped question |
0
|
|
Response Percent |
Response Count |
||
Yes | 98.2% | 111 | |
No, that disease is not treated surgically in my center | 0.0% | 0 | |
No, that disease is treated surgically by other surgeons in my center | 1.8% | 2 |
2. What is your standard surgical approach to non-thymomatous myasthenia gravis? | |||
---|---|---|---|
answered question | 113 | ||
|
skipped question |
0
|
|
Response Percent |
Response Count |
||
Partial sternotomy | 17.7% | 20 | |
Full sternotomy | 50.4% | 57 | |
Transcervical | 5.3% | 6 | |
Thoracoscopic, bilateral | 4.4% | 5 | |
Thoracoscopic, unilateral | 16.8% | 19 | |
Robotic assisted of any type | 5.3% | 6 |
3. What is your intent when performing thymectomy for MG? | |||
---|---|---|---|
answered question | 113 | ||
|
skipped question |
0
|
|
Response Percent |
Response Count |
||
Complete thymectomy | 63.7% | 72 | |
Extended or radical thymectomy | 36.3% | 41 | |
Other | 0.0% | 0 |
4. What are your indications for surgery for MG? | |||
---|---|---|---|
answered question | 112 | ||
|
skipped question |
1
|
|
Response Percent |
Response Count |
||
Any patient diagnosed with MG is a candidate | 49.1% | 55 | |
Disease beyond ocular involvement | 34.8% | 39 | |
Severe generalized disease | 16.1% | 18 |
5. Is older age a contraindication to thymectomy for myasthenia gravis? | |||
---|---|---|---|
answered question | 113 | ||
|
skipped question |
0
|
|
Response Percent |
Response Count |
||
Definitely | 2.7% | 3 | |
Maybe | 30.1% | 34 | |
Probably not | 35.4% | 40 | |
No | 31.9% | 36 |
6. What adjuncts do you or your medical colleagues use to prepare MG patients for surgery (check all that apply)? | |||
---|---|---|---|
answered question | 110 | ||
|
skipped question |
3
|
|
Response Percent |
Response Count |
||
Plasmapheresis | 65.5% | 72 | |
Steroids | 70.9% | 78 | |
Other pharmacologic immunosuppression | 30.9% | 34 | |
Intravenous IgG | 48.2% | 53 |
7. What evaluations are routine prior to thymectomy for MG (check all that apply)? | |||
---|---|---|---|
answered question | 112 | ||
|
skipped question |
1
|
|
Response Percent |
Response Count |
||
CT | 97.3% | 109 | |
PFTs | 39.3% | 44 | |
MRI | 8.0% | 9 | |
Acetylcholine receptor antibody measurement | 53.6% | 60 |
8. If a 1.5 cm encapsulated nodule suspicious for thymoma is discovered intraoperatively during a minimally invasive or transcervical thymectomy, how do you manage this? | |||
---|---|---|---|
answered question | 109 | ||
|
skipped question |
4
|
|
Response Percent |
Response Count |
||
Convert to an open operation | 23.9% | 26 | |
Continue with a minimally invasive approach as planned | 65.1% | 71 | |
Other | 11.0% | 12 |
9. In what region do you practice? | |||
---|---|---|---|
answered question | 113 | ||
|
skipped question |
0
|
|
Response Percent |
Response Count |
||
North America | 31.9% | 36 | |
Europe | 23.0% | 26 | |
Asia | 25.7% | 29 | |
Africa | 5.3% | 6 | |
Central or South America | 13.3% | 15 | |
Australia/New Zealand | 0.9% | 1 |